Alfredo Pascual headshot
EMAIL: [email protected]
PHONE: 720.213.5971

Alfredo Pascual

Based in Germany, Alfredo specializes in international cannabis markets and regulations, drawing upon his extensive academic background in business and public policy. He founded Transnational Cannabis, a consultancy firm that focused on cannabis regulatory frameworks in Europe and Latin America. Previously, he did business development for ICC Labs with a primary focus on developing expansion opportunities internationally.

Argentina redraws medical cannabis rules, allowing home cultivation

Argentinian authorities published a new decree aiming to address the shortcomings of the rules governing the country’s medical cannabis sector, which has largely failed to materialize since an initial law and decree were approved in 2017. The new decree replaces the 2017 version, which did not facilitate meaningful access to medical cannabis and, by extension, […]

Read More

Germany’s medical cannabis flower market shows signs of cooling

Germany imported 1,759 kilograms (3,878 pounds) of medical cannabis flower for pharmacy dispensing during the third quarter of 2020, new data from the Federal Institute for Drugs and Medical Devices (BfArM) shows. This represents a 28% decrease over the previous quarter but is 34% lower than the same quarter last year. However, for the January-September period, […]

Read More

Argentina inches closer to first locally made cannabis medicine

Argentina might have the first locally-manufactured medical cannabis product as soon as early 2021. An official document shared by local pharmaceutical newspaper Pharmabiz shows that Manuel Limeres, head of Argentina’s National Administration of Drugs, Foods and Medical Devices (ANMAT), authorized the company Laboratorio Alef Medical Argentina to register its Convupidiol product as a medicine. The […]

Read More

Epidiolex maker GW Pharma reports record quarterly revenue of $137 million

United Kingdom-based GW Pharmaceuticals posted higher revenue in the quarter ended Sept. 30, largely driven by U.S. sales of its cannabidiol medicine Epidiolex. GW’s total revenue for the third quarter reached $137.1 million, about 16% more than the previous quarter’s $121.3 million. Epidiolex sales in the United States accounted for 87% of the company’s overall […]

Read More

Impact of US election on global cannabis sector to emerge slowly, executives say

Implications of the U.S. elections on the cannabis industry stretch far beyond America’s borders. (Click here for live coverage of the U.S. election results.) Industry executives in countries as far away as Australia, Jamaica and Uruguay are weighing how the results could affect their business prospects. Potential impacts include: Banking. How medical cannabis is controlled […]

Read More

Italy backtracks on medical CBD decree

The Italian Ministry of Health declined to take action under a decree that would have added certain CBD preparations into the table of medicines in its narcotics law, according to a recent notice in the country’s Official Gazette. On Oct. 1, the decree was approved to pave the way for the authorization of sales of […]

Read More

Germany firmly rejects recreational marijuana legalization bill as hope fades for reform

The German federal parliament rejected a bill to legalize a “strictly controlled” adult-use cannabis market, dealing a major setback to recreational marijuana reform efforts in that country. The rejection came despite the fact that a majority of the members of the Bundestag belong to a political party that favors some type of reform. Legalization efforts […]

Read More

More medical cannabis products available in Peruvian pharmacies

The first finished, registered cannabis medicine became available to patients in Peruvian pharmacies this week, Marijuana Business Daily has learned. The product, Epifractan, is manufactured in Uruguay by Ramm Pharma and imported into Peru by Cann Farm, holder of the registry with the Peruvian General Directorate of Medicines, Supplies and Drugs (DIGEMID). Magistral preparations first […]

Read More